BCIQ Profiles

Company Profile Report
0210 Day One
BioCentury & Getty Images

Product Development

With $130M series B, Day One explores new pediatric cancer targets as it prepares for launch

Feb 11, 2021 | 1:40 AM GMT

A $130 million series B round led by RA Capital is enabling pediatric oncology company Day One to pursue new targets

Read the full 511 word article

How to gain access

Continue reading with a
two-week free trial.